Monday, 20 May 2019

You are here

Monocyte Patrolling Contributes to Lupus Glomerulonephritis

Systemic lupus erythematosus (SLE) is an autoimmune disease with a propensity to develop glomerulonephritis (47-70%) or end-stage kidney disease despite therapy.

Hallmarks of the disease are the appearance of immune complexes (IC) containing autoreactive Abs and TLR-activating nucleic acids, whose deposition in kidney glomeruli is suspected to promote tissue injury and glomerulonephritis (GN).

The pathogenesis of lupus GN was investigated using 3 different mouse models of SLE and SLE patients all of whom demonstrated glomerular accumulation of patrolling monocytes (PMos), a cell type with an emerging key function in vascular inflammation.

Lupus nephritis is considered an immune complex–mediated (IC-mediated) form of GN. Although the relevance of ICs in lupus nephritis is debated, IC deposition cand lead to complement-mediated cytotoxicity and end-organ damage.

ICs may also contribute to GN by activating Toll-like receptors (TLR), including TLR7, TLR8, and TLR9, on B cells, further contributing the tissue damage and inflammation. It is possible that the therapeutic efficacy of antimalarials are mediated by the prevention of TLR activation.

A potential B cell–independent mechanism for lupus GN is supported by more than 50 genetic SLE susceptibility loci with functions outside the adaptive immune system. One such susceptibility locus for SLE and lupus GN TNIP1 (TNFAIP3-interacting protein 1; also referred to as ABIN1, A20-binding inhibitor of NF-κB activation 1).  ABIN1 is a negative regulator of the TNFR, TLR, and IL-17R pathways, and, ABIN1-deficient mice develop a systemic lupus-like disease that includes major characteristics of human SLE, including autoreactive Abs and severe GN.

Studies reported in the Journal of Clinical Investigation have shown that monocyte-specific deletion of ABIN1, promoted kidney disease, whereas selective elimination of patrolling monocytes provided protection against GN.

Patrolling monocytes (PMos) are one of the two monocytes found in the peripheral blood (PB), PMos numbers are increased in the PB and kidney glomeruli of lupus.  Investigators have shown that PMos are capable of mediating tissue injury in lupus-nephritis based on studies done to characterize GN in ABIN1-deficient mice and 2 additional independent lupus models. 

These data identify TLR-activated PMos as the principal component of an intravascular process that contributes to glomerular inflammation and kidney injury. based on the SLE susceptibility locus TNFAIP3-interacting protein 1 (TNIP1, also known as ABIN1).

 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Risk Score Predicts Thrombosis Recurrence in APS

A combination risk score helped predict recurrent thrombosis -- particularly arterial -- among patients with antiphospholipid syndrome (APS), an international study found.

Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus

A Morbidity and Mortality Weekly Report on a registry of systemic lupus erythematosus (SLE) patients from two Georgia counties (Fulton and Dekalb) shows SLE mortality was 2-3 times higher compared to the general population, especially amongst blacks; notably deaths occurred sooner after diagnosis and at a mean age approximately 13 years younger.

Calcineurin Inhibitors in Anti-Synthetase Dermatomyositis ILD

A pilot treatment study of patients with anti-aminoacyl-tRNA synthetase antibody–positive polymyositis/dermatomyositis-associated interstitial lung disease (anti-ARS-PM/DM-ILD) shows therapy with glucocorticoids and calcineurin inhibitors (CNI) to be highly effective. 

Biomarkers Predict Thrombosis in Lupus

A composite risk score that included three biomarkers predicted thrombotic events among patients with systemic lupus erythematosus (SLE), a cross-sectional study found.

High GPA Hospital Readmission Rates

A national database reveals that patients with granulomatosis with polyangiitis (GPA) have 22.3% risk of hospital readmissions within 30 days of discharge. 

From a total of 9749 hospital admissions with GPA, there were 2173 readmissions within 30 days of discharge.

The top 5 reasons for readmissions were: